CFG
EDIT icon

Citizens Financial Group’s Editas Medicine EDIT Stock Holding History

Citizens Financial Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$3K – 434
2020
Q2 		$3K Buy
+100
New +$2.61K ﹤0.01% 929

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citizens Financial Group's EDIT Position: Q3 2020 in Review

Citizens Financial Group sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 100 shares — an estimated $3K sold.

Citizens Financial Group first reported a position in EDIT in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

  • Citizens Financial Group reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 100 Editas Medicine shares in Q3 2020, an estimated $3K.
  • Citizens Financial Group first reported a position in Editas Medicine in Q2 2020 and held it in 1 quarter.
  • Citizens Financial Group's Editas Medicine position peaked at $3K in Q2 2020.
  • 239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.